ozempic semaglutide patent expiration date India Obesity Crisis: The Expiry of Ozempic's Patent in 2026 Could Revolutionize India's Battle Against Obesity, ETPharma

Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India

27.58

★★★★☆4.8 (126)

Indian pharma launches low-cost Ozempic generics as patent expires

23.99

★★★★★4.9 (98)

Ozempic just got cheaper in India. But this isn't just about one drug. After Novo Nordisk's patent expiry, multiple Indian pharma companies have launched lower-cost versions of semaglutide- the molecule used for

24.38

★★★★★5.0 (157)

The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open

20.52

★★★★★4.7 (84)

Last week's expiry of the patent for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions

24.01

★★★★★4.9 (203)

Semaglutide (Ozempic) Market: Navigating The Patent Cliff And Strategic Implications

23.23

★★★★★5.0 (176)

The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low-cost

25.26

★★★★★4.8 (132)